Measuring Cutaneous Lesions: Trends in Clinical Practice

Area of Science:

• Dermatology
• Surgical Oncology

Background:

• Accurate cutaneous lesion size measurement is crucial for clinical management, prognosis, and billing.
• Current practices in lesion measurement by healthcare providers lack consistency and standardization.

Purpose of the Study:

• To examine the clinical practices of US dermatologists and dermatologic surgeons in determining cutaneous lesion size.

Main Methods:

• An electronic survey was distributed to members of the American Society for Dermatologic Surgery.
• 426 dermatologists completed the survey on their lesion measurement techniques.

Main Results:

• 85% of dermatologists precisely measure suspected malignant lesions, compared to only 8% for benign lesions.
• Most providers measure lesions themselves, with ~75% confident in visual estimations within 1-2 mm.
• Key reasons for exact measurements include tracking atypical lesions, treatment planning, and billing.

Conclusions:

• Lesion size significantly influences management decisions for most surveyed dermatologists.
• The necessity of exact measurement, especially for benign lesions, is still a point of controversy.
• Further research is needed to determine if exact versus estimated measurements impact patient outcomes.